Profile | GDS4284 / 218244_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 5591.88 | 94 |
GSM687648 | Patient 402 control | 4876.72 | 93 |
GSM687653 | Patient 403 control | 5430.8 | 94 |
GSM687658 | Patient 404 control | 5313.03 | 94 |
GSM687663 | Patient 411 control | 5068.89 | 94 |
GSM687668 | Patient 422 control | 6505.4 | 95 |
GSM687673 | Patient 424 control | 5019.96 | 93 |
GSM687678 | Patient 425 control | 4304.56 | 92 |
GSM687683 | Patient 427 control | 5014.37 | 94 |
GSM687688 | Patient 428 control | 4964.94 | 93 |
GSM687695 | Patient 441 control | 2648.83 | 88 |
GSM687699 | Patient 443 control | 4906.39 | 93 |
GSM687704 | Patient 444 control | 5218.56 | 94 |
GSM687707 | Patient 448 control | 4592.15 | 93 |
GSM687712 | Patient 449 control | 6192.13 | 95 |
GSM687719 | Patient 450 control | 4269.37 | 92 |
GSM687724 | Patient 451 control | 5476.13 | 94 |
GSM687728 | Patient 452 control | 4393.84 | 92 |
GSM687646 | Patient 401 treated 24h | 5058.08 | 93 |
GSM687649 | Patient 402 treated 24h | 5049.35 | 93 |
GSM687665 | Patient 411 treated 24h | 4712.8 | 93 |
GSM687651 | Patient 402 treated 4 weeks | 5178.63 | 94 |
GSM687667 | Patient 411 treated 4 weeks | 5529.05 | 94 |
GSM687670 | Patient 422 treated 24h | 5895.47 | 95 |
GSM687671 | Patient 422 treated 4 weeks | 5741.59 | 94 |
GSM687654 | Patient 403 treated 24h | 5519.93 | 94 |
GSM687675 | Patient 424 treated 24h | 4581.23 | 93 |
GSM687685 | Patient 427 treated 24h | 4908.16 | 93 |
GSM687656 | Patient 403 treated 4 weeks | 4608.07 | 93 |
GSM687677 | Patient 424 treated 4 weeks | 4899.8 | 93 |
GSM687687 | Patient 427 treated 4 weeks | 5259.92 | 94 |
GSM687692 | Patient 428 treated 4h | 5436.85 | 94 |
GSM687716 | Patient 449 treated 4h | 4637.86 | 93 |
GSM687722 | Patient 450 treated 4h | 4698.69 | 93 |
GSM687680 | Patient 425 treated 24h | 4549.31 | 92 |
GSM687690 | Patient 428 treated 24h | 5739.55 | 94 |
GSM687700 | Patient 443 treated 24h | 4053.47 | 92 |
GSM687705 | Patient 444 treated 24h | 5641.5 | 94 |
GSM687714 | Patient 449 treated 24h | 5600.48 | 94 |
GSM687721 | Patient 450 treated 24h | 4498.19 | 93 |
GSM687682 | Patient 425 treated 4 weeks | 4629.3 | 93 |
GSM687694 | Patient 428 treated 4 weeks | 4994.85 | 93 |
GSM687702 | Patient 443 treated 4 weeks | 4351.33 | 92 |
GSM687718 | Patient 449 treated 4 weeks | 4292.35 | 92 |
GSM687723 | Patient 450 treated 4 weeks | 4795.43 | 93 |
GSM687661 | Patient 404 treated 4h | 5077.33 | 93 |
GSM687710 | Patient 448 treated 4h | 4719.06 | 93 |
GSM687726 | Patient 451 treated 4h | 4374.97 | 92 |
GSM687730 | Patient 452 treated 4h | 3188.53 | 91 |
GSM687660 | Patient 404 treated 24h | 3724.1 | 91 |
GSM687697 | Patient 441 treated 24h | 3086.54 | 90 |
GSM687709 | Patient 448 treated 24h | 4686.97 | 93 |
GSM687725 | Patient 451 treated 24h | 5488.72 | 94 |
GSM687729 | Patient 452 treated 24h | 2191.35 | 86 |
GSM687727 | Patient 451 treated 4 weeks | 4809.5 | 93 |
GSM687731 | Patient 452 treated 4 weeks | 4116.05 | 92 |